Skip to content

Bills · 2025-2026 Regular Session

SB 83

Died at session end Official bill text Atom feed

Relating to: utilization management controls for antipsychotic prescription drugs under the Medical Assistance program. (FE)

Drugs Drunken driving Health services department of — Health Medical assistance Medical education United states — Food and drug administration

  1. Introduced, stopped here
  2. Passes Senate, not reached
  3. Passes Assembly, not reached
  4. Governor signs, not reached
  5. Law, not reached

Unfamiliar terms? Glossary

What this bill does

Plain-language analysis by the nonpartisan Legislative Reference Bureau

This bill prohibits the Department of Health Services from imposing any utilization management controls for prescription drugs under the Medical Assistance program that are approved by the federal Food and Drug Administration and are classified as antipsychotic. Utilization management controls are formal techniques used by a health carrier or prescription drug utilization management entity that are designed to evaluate prescription drug medical necessity, appropriateness, efficacy, or efficiency. Currently, DHS administers the Medical Assistance program, which is a joint federal and state program that provides health services to individuals who have limited financial resources.

What it would cost

Fiscal estimates filed by state agencies, as official PDFs

Sponsors

Introduced by: Cabral-Guevara (R) , James (R) , Wanggaard (R)

8 cosponsors

B. Jacobson (R) , Gundrum (R) , Mursau (R) , Novak (R) , Sortwell (R) , Steffen (R) , Subeck (D) , Tittl (R)

Registered lobbying interests · 13

Organizations that registered lobbying activity on this bill with the Wisconsin Ethics Commission. Registration means interest, not a position for or against. Official record

Votes

Senate: Report adoption of Senate Substitute Amendment 2 recommended by Committee on Mental Health, Substance Abuse Prevention, Children and Families, Ayes 3, Noes 2

Passed 3–2 Nov 12, 2025 official source full page

No individual roll call was recorded for this vote. Committee votes and some older sessions record totals only.

Senate: Report passage as amended recommended by Committee on Mental Health, Substance Abuse Prevention, Children and Families, Ayes 3, Noes 2

Passed 3–2 Nov 12, 2025 official source full page

No individual roll call was recorded for this vote. Committee votes and some older sessions record totals only.

Full history

  1. Feb 26, 2025 · Senate

    Introduced by Senators James, Cabral-Guevara and Wanggaard; cosponsored by Representatives Novak, Gundrum, B. Jacobson, Mursau, Sortwell, Steffen and Tittl

  2. Feb 26, 2025 · Senate

    Read first time and referred to Committee on Mental Health, Substance Abuse Prevention, Children and Families

  3. Mar 27, 2025 · Senate

    Fiscal estimate received

  4. May 16, 2025 · Senate

    Senate Substitute Amendment 1 offered by Senator James

  5. Sep 9, 2025 · Senate

    Representative Subeck added as a cosponsor

  6. Oct 3, 2025 · Senate

    Senate Substitute Amendment 2 offered by Senator James

  7. Nov 6, 2025 · Senate

    Public hearing held

  8. Nov 12, 2025 · Senate

    Available for scheduling

  9. Nov 12, 2025 · Senate

    Executive action taken

  10. Nov 12, 2025 · Senate

    Report adoption of Senate Substitute Amendment 2 recommended by Committee on Mental Health, Substance Abuse Prevention, Children and Families, Ayes 3, Noes 2

  11. Nov 12, 2025 · Senate

    Report passage as amended recommended by Committee on Mental Health, Substance Abuse Prevention, Children and Families, Ayes 3, Noes 2

  12. Mar 23, 2026 · Senate

    Failed to pass pursuant to Senate Joint Resolution 1